ARWR实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Jun 2024 @ 00:26):
Our systems believe the stock currently is undervalued by 0.00% compare to its pairs and should correct upwards.

Stats
今日成交量	376 261
平均成交量	1.02M
市值	3.30B
EPS	$-1.020 ( Q2 \| 2024-05-09 )
下一个收益日期	( $-0.580 ) 2024-08-05
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.28 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0470 (0.18%)

AADI -3.52%

ABCL 2.20%

ABCM 0.04%

ABEO -2.14%

ABIO -1.68%

ABOS 0.70%

ABSI 1.53%

ABUS -1.64%

ABVX -1.50%

ACAD -0.64%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -4.11%

ACHV 0.00%

ACIU -0.75%

ACLX 0.95%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.19%

ADGI 0.87%

ADIL 1.75%

ADMA -2.13%

ADPT 0.00%

ADTX -2.08%

ADVM -3.62%

ADXN -1.60%

AEON -5.61%

AEZS -2.49%

AFMD -1.60%

AGEN -2.72%

AGIO -2.25%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -0.08%

AKRO -3.28%

AKTX 1.05%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.46%

ALGS -0.74%

ALKS 0.50%

ALLK -9.36%

ALLO -6.04%

ALLR -0.58%

ALNA 3.16%

ALNY 2.44%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.39%

ALVR 2.98%

ALXN 0.00%

ALXO -13.09%

ALZN 5.27%

AMRN -1.12%

AMTI -3.13%

ANAB 1.09%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.11%

ANPC -3.15%

APGE -0.72%

APGN 8.48%

APGNW 30.65%

APLM -2.32%

APLS 0.32%

APLT -3.04%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.01%

ARDS -14.23%

ARDX 0.17%

ARGX -0.90%

ARNA 0.00%

ARPO -0.90%

ARQT -0.31%

ARTL -2.50%

ARTLW 0.00%

ARVN 4.97%

ARWR -1.06%

ASLN -3.88%

ASMB -5.81%

ASND -1.79%

ATAI -1.85%

ATHA 5.39%

ATHE 0.56%

ATHX -33.50%

ATNF 4.32%

ATOS 0.97%

ATRA -1.93%

ATXI -2.78%

ATXS -0.11%

AUPH -0.99%

AURA 2.79%

AUTL -1.58%

AVBP -3.32%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.47%

AVTX -1.25%

AVXL -4.05%

AXLA 0.00%

AXSM -1.18%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 3.64%

BCAB 5.23%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.83%

BCRX 0.33%

BCTX 8.90%

BCTXW -16.32%

BCYC 0.75%

BDRX -4.64%

BDTX -1.81%

BEAM 1.07%

BFRA -2.91%

BGNE -2.40%

BIOR -6.15%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE -0.04%

BMEA -11.41%

BMRN 0.25%

BNOX 6.22%

BNTC -0.42%

BNTX -1.58%

BOLD -12.19%

BOLT -1.24%

BPMC -0.86%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 24.92%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.59%

CADL -1.95%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 13.05%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.67%

CCCC -5.73%

CCXI 0.00%

CDAK 0.00%

CDIO -2.25%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -7.72%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.20%

CDXS 7.06%

CELC -4.37%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.23%

CERO -3.45%

CEROW -21.56%

CFRX -27.95%

CGEM -3.16%

CGEN -3.05%

CGON -1.78%

CGTX -3.98%

CHMA -6.00%

CHRS 1.27%

CINC 0.00%

CING -0.63%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -1.33%

CLGN 0.34%

CLLS -4.15%

CLNN 1.92%

CLNNW 0.00%

CLRB 6.27%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -1.42%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.47%

CNCE 0.00%

CNSP -36.88%

CNST 0.00%

CNTA -0.45%

CNTB 0.00%

CNTX -7.32%

COCP -2.00%

COEPW 32.45%

COGT -2.64%

CORT 2.75%

COYA -1.46%

CPRX -0.99%

CRBP -3.74%

CRBU -5.97%

CRDF -1.11%

CRGX -0.13%

CRIS -1.72%

CRNX -5.86%

CRSP 0.54%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -4.13%

CTNM -3.21%

CTXR 2.43%

CUE 6.57%

CVAC -4.94%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.42%

CYTO -1.83%

DARE 4.16%

DAWN -1.06%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 30.77%

DNLI -1.52%

DNTH -9.93%

DOMH 2.43%

DRMA -1.68%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.72%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 5.89%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -5.81%

ELOX -5.38%

ELTX -0.88%

ELVN -3.87%

ELYM 2.23%

ENGN -1.72%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 1.58%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.34%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.48%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -2.41%

ETON 1.82%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.40%

EXAI -1.32%

EXEL 0.11%

EYEG -0.69%

EYEN 1.42%

EYPT 0.61%

FATE -9.69%

FBIO 0.85%

FBIOP -0.37%

FBLG -14.69%

FBRX -0.02%

FDMT -3.50%

FENC -1.29%

FGEN -7.27%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.98%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.27%

FULC -3.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -5.36%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.54%

GHRS -2.30%

GLMD -5.09%

GLPG -2.15%

GLSI 1.43%

GLTO -2.16%

GLUE -2.37%

GLYC -10.18%

GMAB -0.23%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX 0.88%

GNPX 0.00%

GNTA 3.94%

GOSS -10.30%

GOVX 0.91%

GOVXW -49.04%

GPCR -8.55%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.31%

GRTX 5.14%

GTHX 0.23%

GUTS -5.08%

GXGXW 41.67%

GYRE -8.37%

HALO -1.05%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.00%

HOOK 2.83%

HOTH -3.51%

HOWL -2.35%

HRMY 1.91%

HRTX 3.77%

HSTO 0.00%

HUMA 0.71%

HUMAW -0.01%

IBRX -4.20%

ICCC 0.22%

ICPT 0.21%

ICU 20.33%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.83%

IFRX -1.54%

IGMS -0.29%

IKNA 1.19%

IKT 0.70%

IMAB 2.03%

IMCR -2.96%

IMGN 0.02%

IMGO 0.00%

IMMP 4.75%

IMMX -7.76%

IMNM 1.00%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -0.75%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -5.09%

INAB -0.56%

INBX 0.76%

INCY -1.28%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.14%

INMB 1.68%

INO -1.30%

INSM -1.28%

INTS -2.75%

INVA 0.56%

INZY 0.69%

IOBT -11.11%

IONS 0.64%

IOVA -3.02%

IPA -0.49%

IPHA 5.58%

IPSC -2.34%

IRON -1.64%

ISEE 0.38%

ITOS -1.71%

ITRM 1.67%

IVA 6.96%

IVVD -2.07%

JAGX 0.79%

JANX -3.65%

JAZZ -0.45%

JNCE 0.00%

JSPR -5.85%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -5.02%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -6.13%

KPRX 0.96%

KPTI -5.05%

KRBP -10.00%

KRON 0.58%

KROS -1.10%

KRRO -8.11%

KRTX 0.03%

KRYS -0.41%

KTRA 8.11%

KTTA -6.79%

KTTAW 0.92%

KURA -0.29%

KYMR -3.00%

KYTX -4.13%

KZIA 2.65%

KZR -0.86%

LABP 0.57%

LBPH -1.18%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.75%

LENZ -4.86%

LEXX 0.78%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.47%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.13%

LPCN -1.86%

LPTX -1.92%

LQDA -0.16%

LRMR -1.56%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -2.79%

LXRX -2.06%

LYEL -35.81%

LYRA 1.16%

MACK 0.10%

MBIO -10.01%

MBRX -1.72%

MCRB 3.17%

MDGL -0.99%

MDNA -13.16%

MDWD -0.34%

MDXG -2.80%

MEIP 1.40%

MESO -1.41%

MGNX -2.80%

MGTA -7.74%

MGTX -3.68%

MGX -2.68%

MIRM -1.18%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.71%

MLYS -7.52%

MNKD 0.38%

MNMD -0.07%

MNOV 2.11%

MNPR -8.52%

MOLN 1.79%

MOR 1.20%

MORF -3.40%

MREO -3.29%

MRKR 2.57%

MRNA -5.89%

MRNS -4.04%

MRSN -2.38%

MRTX -0.17%

MRUS 0.24%

MRVI -1.31%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 5.46%

NAMS 3.34%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.87%

NKGN 10.14%

NKGNW 8.00%

NKTR -4.21%

NKTX -5.38%

NLSP 5.35%

NLSPW 26.67%

NMRA -3.09%

NMTR -42.97%

NOVN -24.84%

NRBO 11.37%

NRIX -2.14%

NRSN -5.12%

NRSNW 0.00%

NRXP -4.58%

NRXPW 18.33%

NRXS 4.82%

NTBL 3.42%

NTEC -12.45%

NTHI 0.00%

NTLA -6.98%

NTRBW -31.07%

NUVL -1.69%

NVAX -2.50%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.58%

OABIW -10.06%

OBIO -3.07%

OBSV 0.00%

OCEA 0.00%

OCGN 3.32%

OCS -1.00%

OCUL -0.08%

OCUP 1.84%

ODT -4.27%

OKYO 1.51%

OLMA -5.29%

OMER -1.03%

OMGA 5.41%

ONCO 4.54%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 1.49%

ONTX -0.47%

ONVO 0.47%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.49%

ORMP 17.41%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.22%

OVID 0.61%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -3.48%

PBYI 1.52%

PCSA 0.00%

PCVX -0.23%

PDSB -4.58%

PEPG 0.09%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -0.83%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.47%

PLUR 7.39%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -5.61%

PRAX 3.19%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.22%

PRQR -0.66%

PRTA -2.31%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.37%

PSTX -1.35%

PTCT -0.51%

PTE -0.82%

PTGX -0.91%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 1.64%

QLGN -3.00%

QNCX 5.70%

QNRX -1.34%

QSI -11.97%

QSIAW -3.13%

QTTB -3.45%

QURE -0.79%

RAIN -1.63%

RANI 6.42%

RAPT -0.98%

RARE 1.27%

RCKT -8.67%

REGN 0.17%

RENB -3.11%

REPL -2.16%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 4.38%

RGLS -6.99%

RGNX -5.56%

RIGL -3.28%

RLAY -3.56%

RLMD 0.35%

RLYB -1.01%

RNA 0.51%

RNAC -2.94%

RNAZ -1.90%

RNXT 0.89%

ROIV -2.08%

ROIVW 4.56%

RPHM 0.00%

RPRX 0.33%

RPTX 0.15%

RUBY 2.70%

RVLP -32.05%

RVMD -0.90%

RVMDW -30.00%

RVNC 0.21%

RVPH -2.38%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.90%

RYTM -5.19%

RYZB 0.02%

RZLT 3.93%

SABS -1.37%

SABSW -11.81%

SAGE 1.19%

SANA -3.69%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.32%

SCPS 0.00%

SEEL -4.12%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.30%

SGMT -2.19%

SGTX -2.56%

SIOX 22.63%

SLDB -9.31%

SLGL 4.12%

SLN -4.57%

SLNO -4.39%

SLRX 5.26%

SLS -1.71%

SMMT -1.75%

SNDX 1.28%

SNGX -4.91%

SNPX -4.44%

SONN -0.01%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.01%

SRRA 0.00%

SRRK -1.98%

SRZN -2.45%

STAB 0.00%

STOK -5.66%

STRO -3.85%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -8.03%

SWTX -0.55%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.14%

TARS 0.45%

TBPH 0.48%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.05%

TECH -0.21%

TENX 1.91%

TERN -8.02%

TFFP -5.33%

TGTX -4.39%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.13%

TNXP -6.00%

TNYA -4.91%

TPST 4.86%

TRDA -4.06%

TRVI 2.30%

TRVN 6.50%

TSHA -22.64%

TSVT -2.93%

TTNP -7.66%

TVTX 1.13%

TYRA -8.54%

UBX -2.48%

UNCY -4.00%

URGN -1.15%

UTHR 0.57%

VACC 11.36%

VALN -4.07%

VAXX 100.00%

VBIV 0.33%

VBLT -8.77%

VCEL 0.74%

VCNX 10.35%

VCYT -1.41%

VERA -3.92%

VERU 0.98%

VERV -2.97%

VIGL 4.84%

VINC 2.28%

VIR 1.08%

VIRI -1.85%

VIRX 3.26%

VKTX -1.34%

VLON -13.04%

VNDA -3.50%

VOR -2.02%

VRCA -0.28%

VRDN -4.55%

VRNA -0.80%

VRPX 0.38%

VRTX 0.32%

VSTM -1.19%

VTGN -0.91%

VTVT -2.97%

VTYX -1.15%

VXRT -4.21%

VYGR -0.38%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.29%

XBIO 1.03%

XBIT -2.92%

XCUR 3.55%

XENE -1.38%

XERS 2.62%

XFOR 4.69%

XLO 3.94%

XLRN 0.00%

XNCR 0.52%

XOMA -2.85%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.73%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-02	Vakiener Victoria	Sell	1 799	Common Stock
2024-04-01	Hamilton James C	Sell	6 000	Common Stock
2024-03-20	Lu Hongbo	Buy	1 000	Common Stock
2024-03-19	Lu Hongbo	Buy	1 000	Common Stock
2024-03-18	Lu Hongbo	Buy	1 000	Common Stock

INSIDER POWER
13.90
Last 100 transactions
Buy: 903 379 \| Sell: 696 131

相关性 (AI algo v.1.1b): Undervalued: 0.00% $26.59 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: 0.12 (neutral)

短: -0.63 (weak negative)

Signal:(55.754) Neutral

Arrowhead Pharmaceuticals 相关性

10 最正相关
OZEM	1
CMTL	0.924
XPON	0.918
AKTX	0.916
TRVN	0.915
BCAN	0.912
AMPH	0.912
ATLC	0.911
FTHM	0.911
NLSP	0.908

10 最负相关
FTGC	-0.91
SWAV	-0.905
TAYD	-0.902
COMT	-0.901
WDC	-0.9
IVCB	-0.899
IMPPP	-0.895
AIRG	-0.892
GHRS	-0.892
BSCO	-0.888

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Arrowhead Pharmaceuticals 相关性 - 货币/商品

0.41
( neutral )

-0.65
( weak negative )

0.00
( neutral )

-0.83
( strong negative )

0.24
( neutral )

-0.64
( weak negative )

Arrowhead Pharmaceuticals 财务报表

Annual	2023
营收:	$240.74M
毛利润:	$228.24M (94.81 %)
EPS:	$-1.920

FY	2023
营收:	$240.74M
毛利润:	$228.24M (94.81 %)
EPS:	$-1.920

FY	2022
营收:	$243.23M
毛利润:	$232.81M (95.72 %)
EPS:	$-1.670

FY	2021
营收:	$138.29M
毛利润:	$0.00 (0.00 %)
EPS:	$-1.360

Financial Reports:

No articles found.

Arrowhead Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in Phase 2b clinical trial to reduce production of angiopoietin-like protein 3; ARO-HSD, which is in Phase 1/2a clinical trial to treat liver diseases; ARO-ENaC, which is in a Phase 1/2a clinical trial to reduce production of the epithelial sodium channel alpha subunit in the airways of the lung; ARO-C3 for the treatment of complement-mediated disease that is in Phase 1/2a clinical trial; ARO-Lung2 for the treatment of chronic obstructive pulmonary disorder; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-XDH to treat uncontrolled gout; ARO-COV for the treatment of COVID-19 and other pulmonary-borne pathogens; and ARO-HIF2, which is in phase 1b clinical trial to treat clear cell renal cell carcinoma. It is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce the production of apolipoprotein A; and ARO-AMG1 for treating genetically validated cardiovascular targets. Arrowhead Pharmaceuticals, Inc. has a license and research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop ARO-JNJ1, ARO-JNJ2, and ARO-JNJ3 RNAi therapeutics for liver-expressed targets; and license and research collaboration agreement with Takeda Pharmaceuticals U.S.A., Inc. to develop RNAi therapeutic candidate as a treatment for liver disease. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California.